Are TNF inhibitors still the agent of choice for RA?

被引：0
|
作者：
Taylor, Peter C. [1 ]
机构：
[1] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskeleta, Oxford, England
来源：
NATURE REVIEWS RHEUMATOLOGY | 2023年
关键词：
RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; METHOTREXATE; COMBINATION; ADALIMUMAB;
D O I：
10.1038/s41584-023-01043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since entering the clinic 25 years ago, biologic TNF inhibitors have transformed the outlook for people with rheumatoid arthritis and set the standard for all other targeted therapies. Despite changes to the therapeutic landscape, TNF inhibitors look set to remain an important treatment option for the foreseeable future.
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al
    Mercer, Louise K.
    Galloway, James B.
    Lunt, Mark
    Davies, Rebecca
    Low, Audrey A. L.
    Dixon, Will G.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (02)
  • [32] TNF-α inhibitors
    Jackson, J. Mark
    DERMATOLOGIC THERAPY, 2007, 20 (04) : 251 - 264
  • [33] TNF inhibitors and infections
    Orenstein, R
    Matteson, EL
    INFECTIONS IN MEDICINE, 2006, 23 (03) : 99 - +
  • [34] TNF inhibitors for psoriasis
    Chima, Margot
    Lebwohl, Mark
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (03) : 134 - 142
  • [35] Update on TNF Inhibitors
    Kerdel, Francisco A.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2016, 35 : S67 - S70
  • [36] Do high levels of IgA rheumatoid factor indicate a poor response to treatment with TNF inhibitors in patients with RA?
    van Laar, Jacob M.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (10): : 544 - 545
  • [37] Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
    Bykerk, Vivian P.
    Ostor, Andrew J. K.
    Alvaro-Gracia, Jose
    Pavelka, Karel
    Ivorra, Jose Andres Romon
    Graninger, Winfried
    Bensen, William
    Nurmohamed, Michael T.
    Krause, Andreas
    Bernasconi, Corrado
    Stancati, Andrea
    Sibilia, Jean
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (12) : 1950 - 1954
  • [38] Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis
    Renton, William D.
    Jung, Jennifer
    Palestine, Alan G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (10):
  • [39] Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange
    van Schie, Karin A.
    Ooijevaar-de Heer, Pleuni
    Dijk, Lisanne
    Kruithof, Simone
    Wolbink, Gertjan
    Rispens, Theo
    SCIENTIFIC REPORTS, 2016, 6
  • [40] Do patients with active RA have differences in disease activity and perceptions if anti-TNF naive versus anti-TNF experienced? Baseline results of the optimization of adalimumab trial
    Pope, Janet
    Thorne, J. Carter
    Haraoui, Boulos Paul
    Psaradellis, Eliofotisti
    Sampalis, John
    MEDICAL SCIENCE MONITOR, 2012, 18 (08): : PI17 - PI20
12345